Headquartered in Missouri, Synergetics USA ( SURG) is a medical device company that designs, manufactures and markets microsurgical instruments. These instruments are used in microsurgery and are often used by ophthalmologists and neurosurgeons. Synergetics is another penny stock that has had a successful 2010. Year-to-date, this health care stock has climbed 113.7% compared to small gains by the broader markets. Equally impressive is the company's quarterly earnings growth of 622.5%, which was reported in its last income statement.
Iridex ( IRIX) is a global provider of therapeutic based laser systems and delivery devices used to treat eye diseases and skin conditions. Its products consist of laser probes that are used in treating eye diseases including diabetic retinopathy, glaucoma and macular degeneration. Over the past 52 weeks, IRIX stock has gained 35.7%. This penny stock has also outperformed earnings estimates for two straight quarters, which has pleased shareholders. A net profit margin of 8.2% last quarter also adds to this stock's impressive resume.
Animal Health International (AHII)
As its name would suggest, Animal Health International ( AHII) distributes animal health products in the U.S. and Canada. Its products include pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment and sanitizers, among others. According to the company, it sells more than 40,000 products to approximately 71,000 customers. The last 52 weeks have been a bumpy ride for AHII, but the penny stock is up 19.8% during that time. Investors are optimistic as analysts have upped earnings estimates to eight cents this quarter and EPS of seven cents last quarter. At $2.60, AHII is a very affordable stock to buy right now.
Simulations Plus (SLP)
Based in Lancaster, Calif., Simulations Plus ( SLP) produces software used for pharmaceutical research and educational purposes. The company also makes computer software and hardware to be used specifically by people with disabilities. Since January, this penny stock is up 93.5%, and it posted a net profit margin of 23.7% last quarter. Likewise, this stock met earnings estimates last quarter, after exceeding expectations in the two prior quarters. Its quarterly earnings growth of 30% year over year also makes this penny stock a valuable buy at this time. As of this writing, Louis Navellier did not own a position in any of the stocks named here.